Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M649Revenue $M89.6Net Margin (%)5.4Z-Score6.3
Enterprise Value $M632EPS $0.2Operating Margin %12.5F-Score5
P/E(ttm))112Cash Flow Per Share $-0.5Pre-tax Margin (%)11.9Higher ROA y-yN
Price/Book9.010-y EBITDA Growth Rate %0Quick Ratio2.8Cash flow > EarningsY
Price/Sales6.25-y EBITDA Growth Rate %0Current Ratio2.8Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %-40.4ROA % (ttm)3.9Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)8.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M44.4ROI % (ttm)9.1Gross Margin Increase y-yN

Gurus Latest Trades with SCMP

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

SCMP is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


SCMP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Claiborne Cary JFormer Chief Financial Officer 2014-12-16Sell50,000$12.915.34view
Kuno Sachiko10% Owner 2014-08-07Sell181,727$6.28116.56view
Ueno Ryuji10% Owner 2014-08-07Sell181,727$6.28116.56view
S&R Technology Holdings, LLC10% Owner 2014-08-07Sell181,727$6.28116.56view
Ueno Ryuji10% Owner 2014-08-04Sell140,873$6.02125.91view
S&R Technology Holdings, LLC10% Owner 2014-08-04Sell140,873$6.02125.91view
Kuno Sachiko10% Owner 2014-08-04Sell140,873$6.02125.91view
Kuno Sachiko10% Owner 2014-07-31Sell400$6.25117.6view
S&R Technology Holdings, LLC10% Owner 2014-07-31Sell400$6.25117.6view
Ueno Ryuji10% Owner 2014-07-31Sell400$6.25117.6view

Press Releases about SCMP :

    Quarterly/Annual Reports about SCMP:

    News about SCMP:

    Articles On GuruFocus.com
    Weekly CEO Sells Highlight: VeriFone Systems Inc, Northeast Utilities, Sucampo Pharmaceuticals Inc, Jan 26 2014 
    Weekly CEO Sells Highlight: Sucampo Pharmaceuticals Inc, Family Dollar Stores Inc, Nike Inc, Hallibu Oct 21 2013 
    comment on SCMP Mar 06 2013 
    Sucampo Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 08 2011 
    Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 03 2010 
    Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 05 2010 
    Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) May 10 2010 
    Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 06 2009 
    Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 07 2009 
    Sucampo Pharmaceuticals Reports Financial Results for the Second Quarter of 2009 Aug 06 2009 


    More From Other Websites
    3 Pharmaceutical Stocks Set for Massive Earnings Growth in 2015 - Stocks in the News Mar 02 2015
    Pacira Misses Earnings Estimates in Q4, Revenues In Line - Analyst Blog Feb 25 2015
    Novartis' Farydak Approved for Multiple Myeloma with Warning - Analyst Blog Feb 24 2015
    Novo Nordisk's Oral Semaglutide Positive in Diabetes Study - Analyst Blog Feb 23 2015
    SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Feb 23 2015
    Sucampo Announces Webcast of Its Presentation at the 2015 Cowen and Company Healthcare Conference Feb 22 2015
    Sucampo Announces Webcast of Its Presentation at the 2015 Cowen and Company Healthcare Conference Feb 22 2015
    Stocks From Leading Industries Feb 21 2015
    Oncolytics Biotech Completes Enrolment for Reolysin Study - Analyst Blog Feb 19 2015
    Celsus Plunges on Dismal Dermatology Drug Study Results - Analyst Blog Feb 18 2015
    Ignyta's Lead Drug Gets Orphan Status for Colorectal Cancer - Analyst Blog Feb 18 2015
    Sucampo Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2014 Earnings Call Feb 18 2015
    Sucampo Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2014 Earnings Call Feb 18 2015
    Novartis' (NVS) Cardiovascular Drug Granted Priority Review - Analyst Blog Feb 16 2015
    Merck KGaA to Gain Full Marketing Rights to Erbitux in Japan - Analyst Blog Feb 16 2015
    Shire Misses on Q4 Earnings, Revenues Beat; Shares Rise - Analyst Blog Feb 13 2015
    Sucampo, Par Pharmaceuticals Enter License Agreement - Analyst Blog Feb 12 2015
    Pacira Resolves Promotion Issues Related to Exparel - Analyst Blog Feb 12 2015
    Sucampo Announces Resolution of Par Pharmaceutical's ANDA for RESCULA(R) Feb 11 2015
    SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Feb 11 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK